Applied DNA Sciences (APDN) 10-K2021 FY Annual report

Filed: 9 Dec 21, 4:13pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: ACDL, acrylic, Alert, antibody, antimicrobial, asymptomatic, Bio, Biocept, booster, Brazil, Chelsea, Chembio, CLEP, cohort, contractor, Cornell, County, covid, CUNY, Egyptian, elicit, enzymatic, extrachromosomal, faculty, Flex, forefront, formally, genome, genomic, incorrectly, injection, isotopic, jeopardizing, KingFisher, KitTM, lieu, lineardna, modality, monthly, mouse, mRNA, mutation, NaN, neutralization, neutralizing, NYSDOH, official, Omicron, OpGen, pattern, pendency, perviouslybeen, predominantly, prime, Purification, random, reflex, region, Roth, RUO, safeCircle, SCCC, school, sera, silico, SoteriaRx, staffing, subcontractor, Suffolk, swab, thirty, TM, turnkey, UK, untitled, unvaccinated, variant, verification, virology, VOC, waive, weekly, workflow, workplace, writeoff

Removed: accrual, APDNW, assessing, back, bearing, capitalized, cashmere, comparability, computed, concurrent, converted, customarily, cycle, default, disclosing, divided, dividing, falling, FUJIFILM, functionality, increasing, inhibit, interfere, interim, internally, lack, leasing, lien, lived, LLP, LoneStar, manager, Marcum, measurement, opportunity, optional, pari, partially, passu, principle, promissory, redeem, relief, retrospective, reviewed, senior, source, succeeding, team, transparency, twenty, unamortized, Wako, whichever, yield

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated APDN transcripts

APDN similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 23.1

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

We consent to the incorporation by reference in the Registration Statement of Applied DNA Sciences, Inc. on Form S-1 (File Nos. 333-233830 and 333-234664), Form S-3 (File Nos. 333-252280, 333-202432, 333-220481, 333-218158, 333-214920, and 333-238557) and S-8 (File Nos. 333-182350, 333-205123, 333-231944 and 333-249365) of our report dated December 9, 2021 which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audits of the consolidated financial statements of Applied DNA Sciences, Inc. as of September 30, 2021 and 2020 and for each of the two years in the period ended September 30, 2021, which report is included in this Annual Report on Form 10-K of Applied DNA Sciences, Inc. for the year ended September 30, 2021.


/s/ Marcum LLP

Marcum LLP
Melville, NY
December 9, 2021